{
  "variants": [
    {
      "variant_string_id": "LRRK2 G2019S",
      "functional_evidence": {
        "phenotypes": [
          "Late-onset loss of dopaminergic neurons",
          "Locomotion deficits",
          "Reduced lifespan",
          "Increased sensitivity to rotenone"
        ],
        "controls": [
          "Wild-type LRRK2 protein (as negative control)",
          "Coexpression of parkin (as protective control)"
        ]
      },
      "acmg_steps": [
        {
          "step": "1. Define disease mechanism",
          "result": "Yes",
          "details": "LRRK2 variants are linked to Parkinsonism via dopaminergic neuron loss, locomotion deficits, lifespan reduction, and mitochondrial dysfunction."
        },
        {
          "step": "2. Evaluate assay applicability",
          "result": "Yes",
          "details": "Transgenic Drosophila models overexpressing LRRK2 variants reflect the disease mechanism (neurodegeneration, mitochondrial toxicity)."
        },
        {
          "step": "3a. Basic controls/replicates",
          "result": "Insufficient",
          "details": "Wild-type control is present, but no explicit mention of replicates or variant controls in the abstract."
        },
        {
          "step": "3b. Accepted assay",
          "result": "Yes",
          "details": "Drosophila models are standard in neurodegenerative disease research, and the assay aligns with known pathogenic mechanisms."
        },
        {
          "step": "3c. Variant controls",
          "result": "No",
          "details": "No explicit mention of pathogenic/benign variant controls in the abstract."
        },
        {
          "step": "4a. Statistical analyses",
          "result": "No",
          "details": "No OddsPath calculation or statistical tests reported for this variant."
        },
        {
          "step": "4b. Control variant counts",
          "result": "Max PS3_supporting",
          "details": "Assumed ≤10 control variants due to lack of explicit data, but assay validity is supported by standard models."
        }
      ],
      "final_evidence_strength": {
        "type": "PS3_supporting",
        "description": "Functional evidence is supportive of pathogenicity, though limited by insufficient replicates and control variant counts."
      }
    },
    {
      "variant_string_id": "LRRK2 Y1699C",
      "functional_evidence": {
        "phenotypes": [
          "Late-onset loss of dopaminergic neurons",
          "Locomotion deficits",
          "Reduced lifespan",
          "Increased sensitivity to rotenone"
        ],
        "controls": [
          "Wild-type LRRK2 protein (as negative control)"
        ]
      },
      "acmg_steps": [
        {
          "step": "1. Define disease mechanism",
          "result": "Yes",
          "details": "LRRK2 variants are linked to Parkinsonism via dopaminergic neuron loss, locomotion deficits, lifespan reduction, and mitochondrial dysfunction."
        },
        {
          "step": "2. Evaluate assay applicability",
          "result": "Yes",
          "details": "Transgenic Drosophila models overexpressing LRRK2 variants reflect the disease mechanism (neurodegeneration, mitochondrial toxicity)."
        },
        {
          "step": "3a. Basic controls/replicates",
          "result": "Insufficient",
          "details": "Wild-type control is present, but no explicit mention of replicates or variant controls in the abstract."
        },
        {
          "step": "3b. Accepted assay",
          "result": "Yes",
          "details": "Drosophila models are standard in neurodegenerative disease research, and the assay aligns with known pathogenic mechanisms."
        },
        {
          "step": "3c. Variant controls",
          "result": "No",
          "details": "No explicit mention of pathogenic/benign variant controls in the abstract."
        },
        {
          "step": "4a. Statistical analyses",
          "result": "No",
          "details": "No OddsPath calculation or statistical tests reported for this variant."
        },
        {
          "step": "4b. Control variant counts",
          "result": "Max PS3_supporting",
          "details": "Assumed ≤10 control variants due to lack of explicit data, but assay validity is supported by standard models."
        }
      ],
      "final_evidence_strength": {
        "type": "PS3_supporting",
        "description": "Functional evidence is supportive of pathogenicity, though limited by insufficient replicates and control variant counts."
      }
    },
    {
      "variant_string_id": "LRRK2 G2385R",
      "functional_evidence": {
        "phenotypes": [
          "Late-onset loss of dopaminergic neurons",
          "Locomotion deficits",
          "Reduced lifespan",
          "Increased sensitivity to rotenone"
        ],
        "controls": [
          "Wild-type LRRK2 protein (as negative control)"
        ]
      },
      "acmg_steps": [
        {
          "step": "1. Define disease mechanism",
          "result": "Yes",
          "details": "LRRK2 variants are linked to Parkinsonism via dopaminergic neuron loss, locomotion deficits, lifespan reduction, and mitochondrial dysfunction."
        },
        {
          "step": "2. Evaluate assay applicability",
          "result": "Yes",
          "details": "Transgenic Drosophila models overexpressing LRRK2 variants reflect the disease mechanism (neurodegeneration, mitochondrial toxicity)."
        },
        {
          "step": "3a. Basic controls/replicates",
          "result": "Insufficient",
          "details": "Wild-type control is present, but no explicit mention of replicates or variant controls in the abstract."
        },
        {
          "step": "3b. Accepted assay",
          "result": "Yes",
          "details": "Drosophila models are standard in neurodegenerative disease research, and the assay aligns with known pathogenic mechanisms."
        },
        {
          "step": "3c. Variant controls",
          "result": "No",
          "details": "No explicit mention of pathogenic/benign variant controls in the abstract."
        },
        {
          "step": "4a. Statistical analyses",
          "result": "No",
          "details": "No OddsPath calculation or statistical tests reported for this variant."
        },
        {
          "step": "4b. Control variant counts",
          "result": "Max PS3_supporting",
          "details": "Assumed ≤10 control variants due to lack of explicit data, but assay validity is supported by standard models."
        }
      ],
      "final_evidence_strength": {
        "type": "PS3_supporting",
        "description": "Functional evidence is supportive of pathogenicity, though limited by insufficient replicates and control variant counts."
      }
    }
  ]
}